1. Home
  2. VANI vs CPBI Comparison

VANI vs CPBI Comparison

Compare VANI & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
    SELLHOLDBUYas of a day ago
  • CPBI
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • VANI 1998
  • CPBI 2023
  • Country
  • VANI United States
  • CPBI United States
  • Employees
  • VANI N/A
  • CPBI N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CPBI
  • Sector
  • VANI Health Care
  • CPBI
  • Exchange
  • VANI Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • VANI 65.2M
  • CPBI N/A
  • IPO Year
  • VANI 2014
  • CPBI N/A
  • Fundamental
  • Price
  • VANI $1.01
  • CPBI $14.81
  • Analyst Decision
  • VANI Strong Buy
  • CPBI
  • Analyst Count
  • VANI 1
  • CPBI 0
  • Target Price
  • VANI $4.00
  • CPBI N/A
  • AVG Volume (30 Days)
  • VANI 114.4K
  • CPBI 3.5K
  • Earning Date
  • VANI 05-12-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • VANI N/A
  • CPBI N/A
  • EPS Growth
  • VANI N/A
  • CPBI 29.70
  • EPS
  • VANI N/A
  • CPBI 1.62
  • Revenue
  • VANI N/A
  • CPBI $18,546,000.00
  • Revenue This Year
  • VANI N/A
  • CPBI N/A
  • Revenue Next Year
  • VANI N/A
  • CPBI N/A
  • P/E Ratio
  • VANI N/A
  • CPBI $9.23
  • Revenue Growth
  • VANI N/A
  • CPBI 13.73
  • 52 Week Low
  • VANI $1.00
  • CPBI $9.96
  • 52 Week High
  • VANI $2.22
  • CPBI $15.50
  • Technical
  • Relative Strength Index (RSI)
  • VANI 33.30
  • CPBI 49.30
  • Support Level
  • VANI $1.00
  • CPBI $14.71
  • Resistance Level
  • VANI $1.16
  • CPBI $14.97
  • Average True Range (ATR)
  • VANI 0.04
  • CPBI 0.11
  • MACD
  • VANI -0.00
  • CPBI 0.00
  • Stochastic Oscillator
  • VANI 6.25
  • CPBI 34.48

Stock Price Comparison Chart: VANI vs CPBI

VANI
CPBI
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April024681012141618202224VANI VS CPBI

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use